AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22564837
Drug: Clarithromycin administered
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin administered intravenously for 3 days
Trial: 1483552
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg/day
Trial: 25074865
Drug: Finasteride 1
RxNorm normalized name: finasteride 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 1 mg tablet
Trial: 11695069
Drug: Nimesulide 100
RxNorm normalized name: nimesulide 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide 100 mg twice daily
Trial: 21640044
Drug: FIN-RACo combination
RxNorm normalized name: Ongo-Fin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FIN-RACo combination therapy (methotrexate, sulfasalazine, hydroxychloroquine, and prednisolone), n=69
Trial: 20173082
Drug: Telcagepant single
RxNorm normalized name: Telcagepant
DrugBank: Telcagepant (DB12228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telcagepant single oral doses (up to 1200 mg)
Trial: 25445851
Drug: Early voice
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early voice therapy (within 4 weeks from injury)
Trial: 9635630
Drug: Leuprolide acetate
RxNorm normalized name: Leuprolide Acetate
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide acetate 7.5 mg
Trial: 17509194
Drug: Letrozole 5
RxNorm normalized name: Letrozole
DrugBank: Letrozole (DB01006)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Letrozole 5 mg
Trial: 15880077
Drug: Laparoscopic living-donor
RxNorm normalized name: Donor Human Stool
DrugBank: Fecal microbiota (DB17743)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic living-donor nephrectomy (L-LDN)
Trial: 8888166
Drug: No specific
RxNorm normalized name: Oregano specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No specific treatment (control)
Trial: 1861510
Drug: Wei Yang
RxNorm normalized name: camphor
DrugBank: Camphor (DB01744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Wei Yang An (easing peptic-ulcer capsule)
Trial: 30629126
Drug: Higher protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher protein weight loss program (1.2-1.5 g/kg/d)
Trial: 21960110
Drug: Hormone receptor-positive
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone receptor-positive subgroup
Trial: 6774845
Drug: 5700 rad
RxNorm normalized name: RAD-IFN
DrugBank: Nadofaragene firadenovec (DB17381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5700 rad in 19 treatments, 24 days overall
Trial: 8949759
Drug: Conformal photon
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conformal photon irradiation (25 patients/78 Gy and 24 patients/83 Gy minimum dose)
Trial: 27278921
Drug: Intravenous ferric
RxNorm normalized name: Ferric Oxide
DrugBank: Ferric oxide (DB11576)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ferric carboxymaltose (FCM) 1000-1500 mg iron
Trial: 27278921
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous sulfate (FS)
Trial: 30652973
Drug: Isoquercetin 1000
RxNorm normalized name: Isoquercetin
DrugBank: Isoquercetin (DB12665)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoquercetin 1000 mg daily for 56 days
Trial: 8587457
Drug: Pentaerithrityltetranitrate (PETN)
RxNorm normalized name: Pentaerythritol tetranitrate
DrugBank: Pentaerythritol tetranitrate (DB06154)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentaerithrityltetranitrate (PETN) treatment
Trial: 16581549
Drug: Succimer treatment
RxNorm normalized name: Succimer
DrugBank: Succimer (DB00566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Succimer treatment
Trial: 25377359
Drug: High-dose ARA-C
RxNorm normalized name: cytarabine
DrugBank: Cytarabine (DB00987)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: High-dose ARA-C (HDAC)
Trial: 25377359
Drug: Standard-dose ARA-C
RxNorm normalized name: cytarabine
DrugBank: Cytarabine (DB00987)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Standard-dose ARA-C (SDAC)
Trial: 31211178
Drug: naproxen 220
RxNorm normalized name: Today's Health Naproxen 220mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naproxen 220 mg b.i.d.
Trial: 2033413
Drug: Alprazolam, 0.5
RxNorm normalized name: Alprazolam, 0.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam, 0.5 mg three times a day
Trial: 21486801
Drug: Control sites
RxNorm normalized name: PAD,BITE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control sites (no treatment)
Trial: 15499953
Drug: 0.5 ml
RxNorm normalized name: ethanol 0.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 ml 30% glucose in spray form
Trial: 2971506
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives
Trial: 11387588
Drug: Enriched food
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enriched food regimen (daily consumption of foods enriched with vitamins and minerals)
Trial: 21123220
Drug: ICD therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICD therapy implanted later than 11 months after MI
Trial: 18598093
Drug: Sildenafil 25
RxNorm normalized name: sildenafil 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 25 mg with DRV/r 400/100 mg
Trial: 18293890
Drug: Early intracoronary
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early intracoronary injection of CD133+ cells
Trial: 20569451
Drug: Bazedoxifene 20
RxNorm normalized name: bazedoxifene 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bazedoxifene 20 mg and 40 mg
Trial: 2264362
Drug: Immunized groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunized groups (both parenteral and oral)
Trial: 6469442
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba extract 600 mg
Trial: 3324563
Drug: Clenbuterol tablets
RxNorm normalized name: clenbuterol
DrugBank: Clenbuterol (DB01407)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clenbuterol tablets (40 micrograms twice daily, later 20 micrograms twice daily)
Trial: 29135651
Drug: Tenofovir film
RxNorm normalized name: Tenofovir
DrugBank: Tenofovir (DB14126)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Tenofovir film (40 mg)
Trial: 10629347
Drug: Glycine 1.0
RxNorm normalized name: LEUCINE 730 mg in 100 mL / PHENYLALANINE 560 mg in 100 mL / LYSINE HYDROCHLORIDE 580 mg in 100 mL / METHIONINE 400 mg in 100 mL / ISOLEUCINE 600 mg in 100 mL / VALINE 580 mg in 100 mL / HISTIDINE 480 mg in 100 mL / THREONINE 420 mg in 100 mL / TRYPTOPHAN 180 mg in 100 mL / ALANINE 2.07 g in 100 mL / GLYCINE 1.03 g in 100 mL / ARGININE 1.15 g in 100 mL / PROLINE 680 mg in 100 mL / TYROSINE 40 mg in 100 mL / SERINE 500 mg in 100 mL INTRAVENOUS INJECTION [Travasol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycine 1.0 g/day
Trial: 23980239
Drug: Placebo mouth-rinse
RxNorm normalized name: phenol
DrugBank: Phenol (DB03255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Placebo mouth-rinse (25 ml for 10 s, administered eight times)
Trial: 17011248
Drug: Glibenclamide 3.5
RxNorm normalized name: Glibenclamide 3.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide 3.5 mg per dose
Trial: 17295799
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) with tablets of HDM extract (n = 55)
Trial: 29696666
Drug: Low-dose NS-0200
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose NS-0200 (1.1 g leucine/0.5 g metformin/0.5 mg sildenafil)
Trial: 21808751
Drug: Olanzapine SOT
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine SOT (10 to 20 mg, once daily)
Trial: 25247897
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% with dexmedetomidine 1 μg/kg (Group I - BD)
Trial: 11119080
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of IRV and INO
Trial: 20727177
Drug: Subgrouping for
RxNorm normalized name: RSV subgroup A stabilized prefusion F protein
DrugBank: Recombinant stabilized RSV A prefusion F antigen (DB18713)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subgrouping for targeted treatment system
Trial: 16116132
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin A (BTX‐A) injections
Trial: 11969277
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (5000 U intravenous bolus, then 30,000 U 24 h(‐1), adjusted to an activated partial thromboplastin time 2‐2.5x normal)
Trial: 10817084
Drug: cytomegalovirus immunoglobulin
RxNorm normalized name: cytomegalovirus immunoglobulin
DrugBank: Human cytomegalovirus immune globulin (DB13886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cytomegalovirus immunoglobulin G levels
Trial: 29911802
Drug: Ephedrine nasal
RxNorm normalized name: ePHEDrine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine nasal spray
Trial: 3710634
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release product E (1.0 g)
Trial: 29141255
Drug: Escitalopram (ESC)
DrugBank: Escitalopram (DB01175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Escitalopram (ESC) 10-30 mg (mean dose 15.2, SD±9.2)
Trial: 10520732
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg amisulpride once daily for 4 days
Trial: 27834418
Drug: Calcium (500
RxNorm normalized name: calcium gluconate 45 mg calcium (500 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (500 mg) and vitamin D (250 IU) supplementation twice a day for 6 months
Trial: 22286551
Drug: Dexamethasone treatment
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone treatment
Trial: 26252749
Drug: Azithromycin 500
RxNorm normalized name: azithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 500 mg
Trial: 9068739
Drug: benzoyl peroxide
RxNorm normalized name: Benzoyl Peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: benzoyl peroxide 5%/erythromycin 3% gel
Trial: 9466049
Drug: 13-cis-retinoic acid
RxNorm normalized name: 13-cis-retinoic acid
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 13-cis-retinoic acid (1 mg/kg/day)
Trial: 15643099
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oxazepam
Trial: 11865786
Drug: EMLA anesthetic
RxNorm normalized name: Emla Anesthetic Disc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMLA anesthetic cream applied for 30 minutes
Trial: 25840429
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (400 mcg) 1 hour prior to surgery
Trial: 25840429
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (400 mcg) 3 hours prior to surgery
Trial: 3315606
Drug: Intravenous anisoylated
RxNorm normalized name: Anisoylated plasminogen streptokinase activator complex
DrugBank: Anistreplase (DB00029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous anisoylated plasminogen streptokinase activator complex (APSAC)
Trial: 9476458
Drug: Benzathine penicillin
RxNorm normalized name: Benzathine penicillin G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzathine penicillin (single dose)
Trial: 28245726
Drug: Tadalafil 5
RxNorm normalized name: tadalafil 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 5 mg orally each night for 28 days
Trial: 23354164
Drug: US-guided in-plain
RxNorm normalized name: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: US-guided in-plain injection
Trial: 11059698
Drug: Monthly reports
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Monthly reports for monitoring subject enrollment and data integrity checks
Trial: 2142949
Drug: Mannitol -
RxNorm normalized name: Mannitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mannitol - 15% at 100 ml/hr
Trial: 301743
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (CABG)
Trial: 28371189
Drug: Glucagon stimulation
RxNorm normalized name: Glucagon
DrugBank: Glucagon (DB00040)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Glucagon stimulation test (GST) with 1 mg i.v. glucagon
Trial: 11243418
Drug: Almotriptan 25
RxNorm normalized name: almotriptan 6.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almotriptan 25 mg
Trial: 11075844
Drug: Almotriptan 6.25
RxNorm normalized name: almotriptan 6.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almotriptan 6.25 mg
Trial: 11743622
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml 1% pilocarpine solution
Trial: 16905851
Drug: Basic therapy
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic therapy
Trial: 2686429
Drug: Ceftazidime plus
RxNorm normalized name: Ceftazidime
DrugBank: Ceftazidime (DB00438)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftazidime plus amikacin followed by oral ciprofloxacin (regimen 3)
Trial: 22929568
Drug: abciximab infusion
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: abciximab infusion with the ClearWay coronary catheter (C)
Trial: 22929568
Drug: thrombectomy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: thrombectomy followed by standard abciximab infusion (T+A)
Trial: 1550080
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) 1,000 mg/m2 intravenously per day for 5 consecutive days in continuous infusion
Trial: 1550080
Drug: 5-FU plus
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU plus cisplatin (CP) 100 mg/m2 on day 1 plus 5-FU on days 2 to 6
Trial: 23360692
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of lutein daily
Trial: 20727555
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 5 mg, vitamin B6 40 mg, and cyanocobalamin 2 mg per day for 3 weeks
Trial: 10048518
Drug: Ulnar nerve
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ulnar nerve block with mepivacaine HCI injection
Trial: 10048518
Drug: Median nerve
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Median nerve block with mepivacaine HCI injection
Trial: 31397611
Drug: Positive control
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive control (no treatment)
Trial: 1094253
Drug: Sequential therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential therapy with conjugated Estrogens (Presomen) and synthetic Gestagen
Trial: 23168298
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (25 μg, 1000 IU)
Trial: 23168298
Drug: Vitamin D2
RxNorm normalized name: vitamin D2
DrugBank: Ergocalciferol (DB00153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin D2 (25 μg, 1000 IU)
Trial: 20864814
Drug: JE vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JE vaccine
Trial: 15650459
Drug: Patient-specific dendritic
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-specific dendritic cell vaccine with GM-CSF, administered subcutaneously once a week for 3 weeks, then once a month for 5 months.
Trial: 16047530
Drug: Depression at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Depression at treatment entry
Trial: 16327334
Drug: Efavirenz 800
RxNorm normalized name: Efavirenz
DrugBank: Efavirenz (DB00625)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Efavirenz 800 mg/day
Trial: 7681050
Drug: Medium dose
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium dose rate brachytherapy (1000 cGy at 5 mm depth for three fractions)
Trial: 1607678
Drug: 5% topical
RxNorm normalized name: BP 5% Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% topical minoxidil
Trial: 3900155
Drug: 2% topical
RxNorm normalized name: A/T/S 2% Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% topical minoxidil
Trial: 19507081
Drug: Consumption of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Consumption of red wine (0.4 ml ethanol per kg per day for 7.5 days)
Trial: 27182031
Drug: IDeg flexible
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IDeg flexible dosing
Trial: 22404081
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment using removable partial dentures
Trial: 8722350
Drug: G-CSF administration
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF administration on day 6 after transplantation (group 2)
Trial: 18706557
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral hormone therapy (E(2) 1 mg plus drospirenone 2 mg/d for 2 months)
Trial: 18706557
Drug: Nonoral hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nonoral hormone therapy (3 mg/d 17beta intranasal E(2) and 200 mg/d vaginal micronized P for 14 days during two 28-day cycles)
Trial: 16461091
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg sildenafil 45 minutes before coitus plus topical EMLA cream applied 15 minutes before coitus for 2 months (Group 3)
Trial: 16461091
Drug: Topical EMLA-cream-only
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical EMLA-cream-only for 2 months (Group 4)
Trial: 6119780
Drug: Cimetidine 200
RxNorm normalized name: cimetidine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 200 mg t.d.s. and 400 mg at night
Trial: 18807128
Drug: omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: omeprazole 20 mg
Trial: 17533782
Drug: Topical cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclosporine ophthalmic emulsion
Trial: 12358335
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone (BDP)
Trial: 2839444
Drug: Post-operative thoracic
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-operative thoracic radiation with systemic chemotherapy (cytoxan, adriamycin, and platinum) for 6 months
Trial: 15164445
Drug: Cytoreduction followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cytoreduction followed by hyperthermic intraperitoneal chemotherapy (HIPEC)
Trial: 12583553
Drug: clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: clarithromycin 500 mg + amikacin 250 mg i.v. b.i.d.
Trial: 20108648
Drug: 333 mg
RxNorm normalized name: aspirin 333 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 333 mg acamprosate calcium
Trial: 20108648
Drug: 666 mg
RxNorm normalized name: lactulose 666 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 666 mg acamprosate calcium
Trial: 7611579
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside (SNP) infusion to reduce mean arterial blood pressure to 50 mmHg